Apparently, some ENTA investors and prospective investors are more bearish than I am
Clearly. At least to me, the largest issue is whether ENTA/ABBV are really "behind" since the current drug may be being used for the tageted ENTA/ABBV patients and thereby "cured." Seems to early to tell, but the issue is surely more front and center. Feel free to correct me (as if I need to say that).
Market Data 
Markets 
AI
